Agios Pharmaceuticals Cash Flow Statement (2012-2026) | AGIO

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-3.43M-4.51M3.96M-82.52M-85.45M-91.32M-95.94M-83.18M-97.70M947.91M-96.52M-90.54M-112.54M-103.43M-108.04M-99.23M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)
14.88M12.15M11.62M15.51M11.16M11.16M11.46M10.14M11.74M9.08M13.81M9.23M11.56M11.14M10.90M11.36M14.69M12.38M14.12M15.54M
Deferred Taxes (Quarter)
Cash from Discontinued Operations (Quarter)
-48.29M-10.32M-4.10M
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)
-0.10M0.52M0.16M0.08M-0.20M0.03M-0.58M0.04M0.11M-0.11M43.11M0.19M1.31M-1.50M0.12M0.03M
Non-cash Items (Quarter)
Cash from Operations (Quarter)
-69.00M-164.00M9.14M-97.73M-74.23M-71.35M-66.16M-95.18M-66.75M-61.64M-72.49M-99.87M-72.59M-84.22M-133.17M-111.49M-77.12M-88.15M-96.21M-118.92M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-1.76M-1.90M14.86M2.44M-3.82M0.66M1.92M2.78M2.49M2.70M2.75M2.53M2.61M3.43M5.92M1.35M4.75M-0.65M1.75M1.14M
Amortization of Deferred Charges (Quarter)
2.34M2.37M
Depreciation & Amortization (CF) (Quarter)
2.35M2.21M2.20M2.48M2.29M1.98M1.81M1.79M1.81M1.62M1.40M1.35M1.59M1.34M1.37M1.28M1.26M1.37M1.27M1.36M
Change in Working Capital
Change in Receivables (Quarter)
8.13M-1.14M-6.99M0.54M-2.21M1.07M2.81M-0.43M0.47M-1.07M1.63M0.64M0.31M-0.64M0.99M-0.77M1.64M0.04M5.55M5.55M
Change in Inventory (Quarter)
2.48M1.57M1.12M3.32M2.88M4.30M1.60M1.80M3.99M0.87M2.49M1.19M1.99M1.24M1.19M0.89M2.17M
Change in Account Payables (Quarter)
-2.62M2.22M5.20M-5.01M-2.24M2.62M8.06M-9.80M2.96M1.64M-3.53M1.43M-1.16M7.09M-0.76M-2.82M3.90M1.81M-1.15M-4.99M
Change in Accured Expenses (Quarter)
10.15M-0.12M2.67M-12.22M8.64M1.37M0.59M-7.89M6.73M1.30M12.68M-18.04M11.61M-3.44M13.55M-26.10M14.53M1.93M8.24M-19.17M
Change in Taxes (Quarter)
52.68M-51.81M-0.19M-0.68M
Investing Activities
Capital Expenditures (Quarter)
0.25M-0.78M1.19M2.80M-2.79M4.76M0.11M0.40M-0.39M0.76M-0.71M0.30M-0.24M1.62M0.77M-0.64M0.21M3.98M0.67M
Sales of Property, Plant and Equipment (Quarter)
0.96M0.15M1.18M0.04M
Divestments (Quarter)
Change in Acquisitions & Divestments (Quarter)
139.13M219.76M336.89M332.15M336.57M278.58M198.88M186.20M151.26M151.04M186.19M368.72M141.95M157.58M150.13M288.26M220.64M272.09M252.27M290.26M
Cash from Investing Activities (Quarter)
1,504.79M-232.73M-1897.36M-26.57M82.81M104.07M82.95M57.60M47.12M39.34M95.51M124.56M37.24M250.79M-49.16M112.59M78.97M95.56M90.08M141.31M
Financing Activities
Other financing activities (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
25.67M4.01M0.27M1.29M0.02M1.27M0.10M2.47M0.24M1.88M0.85M5.86M1.10M2.64M4.84M1.62M0.07M4.43M2.56M2.08M
Shares Repurchased (Quarter)
254.39M19.05M
Misc.
Cash from Financing Activities (Quarter)
-503.46M-250.99M-18.59M1.21M-0.07M1.19M0.02M2.47M0.24M1.88M0.85M5.86M1.10M2.64M4.84M1.62M0.07M4.43M2.56M2.08M
Change in Cash (Quarter)
-918.90M-568.90M-197.10M-123.10M8.52M33.91M16.81M-35.12M-19.39M-20.42M23.87M30.56M-34.25M169.21M-177.48M2.72M1.91M11.84M-3.58M24.47M
Free Cash Flow (Quarter)
-69.25M-163.22M7.95M-100.54M-71.44M-76.11M-66.28M-95.58M-66.36M-62.40M-71.78M-99.87M-72.89M-83.98M-134.79M-112.25M-76.48M-88.36M-100.19M-119.59M
Net Cash Flow (Quarter)
932.33M-647.71M-1906.80M-123.10M8.52M33.91M16.81M-35.12M-19.39M-20.42M23.87M30.56M-34.25M169.21M-177.48M2.72M1.91M11.84M-3.58M24.47M